Rak prostate je drugi najpogostejši rak pri moških po vsem svetu, pri čemer je bilo v letu 2018 prijavljenih približno 1,276 milijonov novih primerov, kar predstavlja 7,1% vseh primerov raka pri moških.
Visoka je tudi stopnja umrljivosti zaradi raka prostate, leta 2018 je po ocenah po vsem svetu umrlo 37.005 ljudi.
Vendar pa se stopnja umrljivosti zelo razlikuje glede na regijo, pri čemer ima Zahodna Afrika peto najvišje tveganje za smrtnost zaradi raka prostate na svetu, Nigerija pa ima največje prebivalstvo in gospodarstvo v tej regiji.
V Nigeriji je rak prostate najpogostejši in najbolj smrtonosen rak za moške, s približno 32,8 primeri in 16,3 smrtnimi primeri na 100.000 moških.
To je več kot dvakrat več kot smrtnost v Severni Ameriki.
Pozno odkrivanje bolezni, omejeni viri za pregled in odkrivanje ter zmanjšana dokumentacija in poročanje o primerih prispevajo k visoki stopnji umrljivosti v Nigeriji.
V Združenih državah je rak prostate drugi najpogostejši vzrok smrti zaradi raka pri moških, vsako leto pa zaradi te bolezni umre približno 40.000 moških.
Stopnja smrtnosti zaradi raka prostate se je od začetka devetdesetih let počasi zmanjševala, vendar je še vedno pomembna zdravstvena težava.
Na splošno je rak prostate smrtonosna bolezen, zlasti v regijah z omejenim dostopom do zdravstvene oskrbe in presejalnih virov.
Vendar pa lahko zgodnje odkrivanje in zdravljenje znatno izboljšajo izide in zmanjšajo stopnjo umrljivosti.
Nakata S, Takahashi H, Ohtake N, Takei T, Yamanaka H: Trends and characteristics in prostate cancer mortality in Japan. Int J Urol. 2000, 7 (7): 254-7.
Pishgar F, Ebrahimi H, Saeedi Moghaddam S, Fitzmaurice C, Amini E: Global, Regional and National Burden of Prostate Cancer, 1990 to 2015: Results from the Global Burden of Disease Study 2015. J Urol. 2018, 199 (5): 1224-1232.
Cai Q, Chen Y, Zhang D, Pan J, Xie Z, Xu C, Li S, Zhang X, Gao Y, Hou J, Guo X, Zhou X, Zhang B, Ma F, Zhang W, Lin G, Xin Z, Niu Y, Wang Y: Estimates of over-time trends in incidence and mortality of prostate cancer from 1990 to 2030. Transl Androl Urol. 2020, 9 (2): 196-209.
Feletto E, Bang A, Cole-Clark D, Chalasani V, Rasiah K, Smith DP: An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? World J Urol. 2015, 33 (11): 1677-87.
Taksler GB, Keating NL, Cutler DM: Explaining racial differences in prostate cancer mortality. Cancer. 2012, 118 (17): 4280-9.
Opozorilo: medicinsko
Ta spletna stran je namenjena samo izobraževalnim in informacijskim namenom in ne pomeni zagotavljanja zdravniških nasvetov ali strokovnih storitev.
Posredovani podatki se ne smejo uporabljati za diagnozo ali zdravljenje zdravstvenega problema ali bolezni, tisti, ki iščejo osebni zdravniški nasvet, pa se morajo posvetovati z licenciranim zdravnikom.
Upoštevajte, da je nevronska mreža, ki ustvarja odgovore na vprašanja, še posebej netočna, ko gre za številčno vsebino, na primer število ljudi, diagnosticiranih z določeno boleznijo.
Vedno poiščite nasvet svojega zdravnika ali drugega usposobljenega zdravstvenega delavca glede zdravstvenega stanja. Nikoli ne prezrite strokovnega zdravniškega nasveta ali odložite iskanja zaradi nečesa, kar ste prebrali na tej spletni strani. Če menite, da imate zdravniški nujen primer, pokličite 911 ali takoj pojdite v najbližjo urgenco. Ta spletna stran ali njena uporaba ne ustvarja nobenega odnosa med zdravnikom in bolnikom. Niti BioMedLib niti njeni zaposleni, niti kateri koli sodelavec na tej spletni strani ne daje nobenih izjav, izrecnih ali implicitnih, v zvezi z informacijami, ki so na voljo na tej spletni strani ali z njeno uporabo.
Opozorilo: avtorske pravice
Zakon o avtorskih pravicah za digitalno tisočletje iz leta 1998, 17 U.S.C. § 512 (DMCA) zagotavlja sredstva za lastnike avtorskih pravic, ki menijo, da material, ki se pojavlja na internetu, krši njihove pravice v skladu z ameriškim zakonom o avtorskih pravicah.
Če v dobri veri menite, da katera koli vsebina ali material, ki je na voljo v povezavi z našo spletno stranjo ali storitvami, krši vaše avtorske pravice, nam lahko (ali vašemu zastopniku) pošljete obvestilo, v katerem zahtevate odstranitev vsebine ali materiala ali blokiranje dostopa do njega.
Obvestila je treba poslati v pisni obliki po e-pošti (za e-poštni naslov glejte razdelek "Kontakt").
DMCA zahteva, da vaše obvestilo o domnevni kršitvi avtorskih pravic vključuje naslednje informacije: (1) opis avtorsko varovanega dela, ki je predmet domnevne kršitve; (2) opis domnevne vsebine, ki krši avtorske pravice, in informacije, ki so zadostne, da nam omogočijo iskanje vsebine; (3) kontaktne informacije za vas, vključno z vašim naslovom, telefonsko številko in e-poštnim naslovom; (4) izjavo, da imate v dobri veri prepričanje, da vsebina na način, o katerem se pritožujete, ni odobrena s strani imetnika avtorskih pravic ali njegovega zastopnika ali z delovanjem katerega koli zakona;
(5) vašo izjavo, podpisano pod kaznijo krivokletstva, da so informacije v uradnem obvestilu točne in da imate pooblastilo za uveljavljanje avtorskih pravic, ki naj bi bile kršene;
in (6) fizični ali elektronski podpis imetnika avtorskih pravic ali osebe, pooblaščene, da deluje v imenu imetnika avtorskih pravic.
Če ne vključite vseh zgornjih informacij, se lahko obravnava vaše pritožbe odloži.
Kontaktni podatki
Prosimo, pošljite nam e-pošto s kakršnim koli vprašanjem / predlogom.
How deadly is prostate cancer?
Prostate cancer is the second most common cancer in men worldwide, with an estimated 1.276 million new cases reported in 2018, representing 7.1% of all cancer cases in men.
The mortality rate for prostate cancer is also high, with an estimated 37,005 deaths worldwide in 2018.
However, the mortality rate varies greatly by region, with Western Africa having the fifth-highest risk for prostate cancer mortality in the world, and Nigeria having the largest population and economy in this region.
In Nigeria, prostate cancer is both the most common and most deadly cancer for men, with an estimated 32.8 cases and 16.3 deaths per 100,000 men.
This is more than double the death rate in North America.
Late detection of the disease, limited resources for screening and detection, and decreased documentation and reporting of cases contribute to the high mortality rate in Nigeria.
In the United States, prostate cancer is the second most common cause of cancer death in men, with approximately 40,0000 men dying from the disease each year.
The prostate cancer death rate has been slowly decreasing since the early 1990s, but it remains a significant health concern.
Overall, prostate cancer is a deadly disease, particularly in regions with limited access to medical care and screening resources.
However, early detection and treatment can significantly improve outcomes and reduce mortality rates.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Približno
BioMedLib uporablja avtomatizirane računalnike (algoritme strojnega učenja) za ustvarjanje parov vprašanj in odgovorov.
Začeli smo s 35 milijoni biomedicinskih publikacij PubMed/Medline in spletnih strani RefinedWeb.
